RxDoctor Payments Data

Joshua Schiffman, MD

Anesthesiology · Philadelphia, PANPI 1881954170

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Cumberland Pharmaceuticals, Inc. at 42.1% of the total. Reporting peaked in 2022 at $218 and has fallen 68.9% since, to $68 in 2025. Among anesthesiology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$894in general payments, 2019–2025

Across 60 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cumberland Pharmaceuticals, Inc.$376
  • Chiesi USA, Inc.$193
  • Merck$129
  • Heron Therapeutics, Inc.$41
  • Werfen USA LLC$38
  • Redhill Biopharma Inc.$25
  • plus $92 from 6 others

What the payments were for

  • Food & beverage$894100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$894 in reported general payments places this provider in the 90th percentile of 2,015 anesthesiology providers in Pennsylvania.

See all anesthesiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$43,110
Medicare patients
248
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →